Acotec Scientific Holdings Full Year 2024 Earnings: Misses Expectations

Simply Wall St · 03/26 00:07

Acotec Scientific Holdings (HKG:6669) Full Year 2024 Results

Key Financial Results

  • Revenue: CN¥534.0m (up 13% from FY 2023).
  • Net income: CN¥52.3m (up 261% from FY 2023).
  • Profit margin: 9.8% (up from 3.1% in FY 2023). The increase in margin was driven by higher revenue.
  • EPS: CN¥0.17 (up from CN¥0.048 in FY 2023).
earnings-and-revenue-growth
SEHK:6669 Earnings and Revenue Growth March 26th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Acotec Scientific Holdings Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 6.5%. Earnings per share (EPS) also missed analyst estimates by 35%.

The company's shares are down 9.6% from a week ago.

Balance Sheet Analysis

Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We've done some analysis and you can see our take on Acotec Scientific Holdings' balance sheet.